JP5710241B2 - Liquid oral composition - Google Patents
Liquid oral composition Download PDFInfo
- Publication number
- JP5710241B2 JP5710241B2 JP2010291908A JP2010291908A JP5710241B2 JP 5710241 B2 JP5710241 B2 JP 5710241B2 JP 2010291908 A JP2010291908 A JP 2010291908A JP 2010291908 A JP2010291908 A JP 2010291908A JP 5710241 B2 JP5710241 B2 JP 5710241B2
- Authority
- JP
- Japan
- Prior art keywords
- component
- mass
- astringency
- liquid oral
- bitterness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 35
- 239000007788 liquid Substances 0.000 title claims description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- 210000000214 mouth Anatomy 0.000 claims description 18
- 235000011187 glycerol Nutrition 0.000 claims description 10
- 150000005846 sugar alcohols Chemical class 0.000 claims description 8
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 7
- 239000004376 Sucralose Substances 0.000 claims description 5
- 235000019408 sucralose Nutrition 0.000 claims description 5
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000004386 Erythritol Substances 0.000 claims description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- 235000019414 erythritol Nutrition 0.000 claims description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 3
- 229940009714 erythritol Drugs 0.000 claims description 3
- 239000000845 maltitol Substances 0.000 claims description 3
- 235000010449 maltitol Nutrition 0.000 claims description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 3
- 229940035436 maltitol Drugs 0.000 claims description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- 235000019606 astringent taste Nutrition 0.000 description 29
- 235000019658 bitter taste Nutrition 0.000 description 21
- 239000002324 mouth wash Substances 0.000 description 15
- 229940051866 mouthwash Drugs 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 9
- 235000002639 sodium chloride Nutrition 0.000 description 9
- 235000019640 taste Nutrition 0.000 description 9
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 159000000003 magnesium salts Chemical class 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 150000003751 zinc Chemical class 0.000 description 4
- 206010013911 Dysgeusia Diseases 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- -1 chlorohydroxyaluminum Chemical compound 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000551 dentifrice Substances 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- KRLBLPBPZSSIGH-CSKARUKUSA-N (6e)-3,7-dimethylnona-1,6-dien-3-ol Chemical compound CC\C(C)=C\CCC(C)(O)C=C KRLBLPBPZSSIGH-CSKARUKUSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000270722 Crocodylidae Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- ZEMWIYASLJTEHQ-UHFFFAOYSA-J aluminum;sodium;disulfate;dodecahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.[Na+].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O ZEMWIYASLJTEHQ-UHFFFAOYSA-J 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 201000002170 dentin sensitivity Diseases 0.000 description 1
- LNNWVNGFPYWNQE-GMIGKAJZSA-N desomorphine Chemical compound C1C2=CC=C(O)C3=C2[C@]24CCN(C)[C@H]1[C@@H]2CCC[C@@H]4O3 LNNWVNGFPYWNQE-GMIGKAJZSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- GNHOJBNSNUXZQA-UHFFFAOYSA-J potassium aluminium sulfate dodecahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.[Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GNHOJBNSNUXZQA-UHFFFAOYSA-J 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 235000011127 sodium aluminium sulphate Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 235000013904 zinc acetate Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、使用感の良好な液体口腔用組成物に関する。 The present invention relates to a liquid oral composition having a good feeling of use.
アルミニウム塩、亜鉛塩、マグネシウム塩等の金属塩は優れた収斂作用に基づき、歯肉をひきしめ、炎症を抑制し、止血作用、象牙質知覚過敏症の症状を緩和する作用等を有することから、歯周病や歯肉炎予防用の歯磨剤や洗口剤に配合されている。
ところが、これらの収斂剤を多量に含有する口腔用組成物は、白濁や沈殿を生じる、苦味や渋味を有する等の問題があった。かかる欠点を抑制すべく、鎖式炭化水素化合物やロウ類を配合する(特許文献1、2)、糖アルコールを配合する(特許文献3)、アミノ酸や蛋白質を配合しpHを調整する(特許文献4)、フッ素との配合比率を調整する(特許文献5)等が行なわれている。
Metal salts such as aluminum salts, zinc salts, and magnesium salts are based on an excellent astringent action, and have the effect of squeezing the gums, suppressing inflammation, hemostasis, and alleviating symptoms of dentin hypersensitivity. It is included in dentifrices and mouthwashes for the prevention of periodontal disease and gingivitis.
However, oral compositions containing a large amount of these astringents have problems such as cloudiness and precipitation, and bitterness and astringency. In order to suppress such disadvantages, a chain hydrocarbon compound or wax is blended (Patent Documents 1 and 2), a sugar alcohol is blended (Patent Document 3), an amino acid or a protein is blended to adjust the pH (Patent Document) 4), the blending ratio with fluorine is adjusted (Patent Document 5).
しかしながら、これらの技術によっては、苦味や渋味を十分に抑制できなかったり、苦味、渋味を抑制できるが収斂感も失われ、種々の成分を多量に配合すると、例えば炭化水素等を多量に配合すると歯磨剤や洗口剤としての使用感が大きく損なわれてしまうという新たな問題も生じた。かかる口腔内の使用感の問題は練歯磨剤よりも洗口剤等のような液体口腔用組成物において特に顕著である。
従って、本発明の課題は、十分な収斂感を有しつつ、苦味、渋味などの味が改善された液体口腔用組成物を提供することにある。
However, depending on these technologies, bitterness and astringency cannot be sufficiently suppressed, bitterness and astringency can be suppressed, but astringency is lost. When it mix | blends, the new problem that the usability as a dentifrice or a mouthwash will be spoiled greatly also arises. Such a problem of use feeling in the oral cavity is particularly remarkable in a liquid oral composition such as a mouthwash rather than a toothpaste.
Accordingly, an object of the present invention is to provide a liquid oral composition having improved astringency such as bitterness and astringency while having a sufficient astringency.
そこで本発明者は、アルミニウム塩等の収斂成分と種々の成分を組み合せて配合し、その収斂作用及び味等について検討してきたところ、収斂成分に、2〜9質量%のグリセリンと一定量のスクラロースと一定量の糖アルコールとを組み合せて配合し、多量の水を含む液体口腔用組成物にすると、収斂感を有しつつ、組成物を口腔内に適用中の苦味や渋味が低減されるだけでなく、全く意外にも、当該組成物を口腔内に適用後の後味が顕著に良好になることを見出し、本発明を完成した。 Therefore, the present inventor has combined astringent ingredients such as aluminum salts with various ingredients and studied the astringent action and taste, and as a result, 2-9 mass% glycerin and a certain amount of sucralose are contained in the astringent ingredients. When a liquid oral composition containing a large amount of water is combined with a certain amount of sugar alcohol, the bitterness and astringency during application of the composition to the oral cavity is reduced while having a sense of convergence. Not only surprisingly, the present inventors have found that the aftertaste after applying the composition into the oral cavity is remarkably improved, and completed the present invention.
すなわち、本発明は、次の成分(A)〜(E):
(A)水溶性アルミニウム塩、水溶性亜鉛塩及び水溶性マグネシウム塩から選ばれる多価金属塩 0.02〜0.3質量%、
(B)グリセリン 2〜9質量%、
(C)スクラロース 0.002〜0.01質量%、
(D)糖アルコール 0.5〜10質量%、及び
(E)水 75〜95質量%
を含し、成分(B)と成分(A)の質量比(B/A)が20〜90であって、成分(C)と成分(A)の質量比(C/A)が0.02〜0.1である液体口腔用組成物を提供するものである。
That is, the present invention includes the following components (A) to (E):
(A) Polyvalent metal salt selected from water-soluble aluminum salt, water-soluble zinc salt and water-soluble magnesium salt 0.02 to 0.3% by mass,
(B) Glycerin 2-9% by mass,
(C) Sucralose 0.002-0.01% by mass,
(D) Sugar alcohol 0.5-10 mass% and (E) Water 75-95 mass%
The mass ratio (B / A) of component (B) to component (A) is 20 to 90, and the mass ratio (C / A) of component (C) to component (A) is 0.02. The liquid oral composition which is -0.1 is provided.
本発明の液体口腔用組成物を用いれば、収斂成分による優れた収斂感を有しつつ、苦味、渋味などの味が改善され、しかも、液体口腔用組成物を口腔内への適用後までも苦味、渋味が低減される結果、適用中から適用後までも使用感が良好である。 When the liquid oral composition of the present invention is used, the taste such as bitterness and astringency is improved while having an excellent astringent feeling due to the astringent component, and until the liquid oral composition is applied to the oral cavity. As a result, bitterness and astringency are reduced, and the feeling of use is good from application to application.
本発明に用いられる(A)水溶性アルミニウム塩、水溶性亜鉛塩及び水溶性マグネシウム塩から選ばれる多価金属塩は、収斂作用を奏し、歯肉のひきしめ、抗炎症作用等を示す成分である。このうち、収斂効果と苦味抑制の点から水溶性アルミニウム塩が好ましい。水溶性アルミニウム塩としては、乳酸アルミニウム、クロルヒドロキシアルミニウム、アラントインヒドロキシアルミニウム、アラントインクロルヒドロキシアルミニウム、アラントインジヒドロキシアルミニウム、パラフェノールスルホン酸アルミニウム、塩化アルミニウム、ミョウバン(硫酸カリウムアルミニウム十二水和物)、ナトリウムミョウバン(硫酸ナトリウムアルミニウム十二水和物)硝酸アルミニウム等が挙げられ、収斂効果及び渋味抑制の点から、このうちアラントインクロルヒドロキシアルミニウム、アラントインジヒドロキシアルミニウムが特に好ましい。 The polyvalent metal salt selected from (A) a water-soluble aluminum salt, a water-soluble zinc salt and a water-soluble magnesium salt used in the present invention is a component that exhibits an astringent action, a gingival squeezing action, an anti-inflammatory action, and the like. Of these, water-soluble aluminum salts are preferred from the viewpoints of astringency and bitterness control. Water-soluble aluminum salts include aluminum lactate, chlorohydroxyaluminum, allantoinhydroxyaluminum, allantoinchlorohydroxyaluminum, allantoindihydroxyaluminum, aluminum paraphenolsulfonate, aluminum chloride, alum (potassium aluminum sulfate dodecahydrate), sodium alum (Sodium aluminum sulfate dodecahydrate) Aluminum nitrate and the like can be mentioned. Of these, allantoinchlorohydroxyaluminum and allantoindihydroxyaluminum are particularly preferred from the viewpoints of astringency and astringency.
水溶性亜鉛塩としては、パラフェノールスルホン酸亜鉛塩、塩化亜鉛、グルコン酸亜鉛、酢酸亜鉛、硫酸亜鉛等が挙げられる。 Examples of the water-soluble zinc salt include paraphenolsulfonic acid zinc salt, zinc chloride, zinc gluconate, zinc acetate, and zinc sulfate.
水溶性マグネシウム塩としては、グルコン酸マグネシウム、硫酸マグネシウム、塩化マグネシウム等が挙げられる。 Examples of the water-soluble magnesium salt include magnesium gluconate, magnesium sulfate, magnesium chloride and the like.
成分(A)の多価金属塩は、本発明の液体口腔用組成物中に0.02〜0.3質量%含有する。この範囲であれば、十分な収斂作用を奏し、かつ苦味、渋味が抑制される。より好ましい含有量は0.05〜0.2質量%であり、さらに好ましくは0.075〜0.15質量%である。 The polyvalent metal salt of component (A) is contained in the liquid oral composition of the present invention in an amount of 0.02 to 0.3% by mass. If it is this range, there will be sufficient convergence effect and bitterness and astringency will be suppressed. More preferable content is 0.05-0.2 mass%, More preferably, it is 0.075-0.15 mass%.
本発明に用いられる(B)グリセリンは、成分(A)の多価金属塩の味を改善する作用を有する。グリセリンの含有量は、本発明組成物を口腔内適用中及び適用後の苦味、渋味改善効果、及び収斂感を維持する点から液体口腔用組成物中2〜9質量%であり、より好ましくは2.5〜8.5質量%、さらに好ましくは3〜8質量%である。グリセリンの含有量が少ない場合には味の改善作用が十分でなく、多すぎる場合は、甘味が強すぎ、後味が悪くなり収斂感が失われる。 (B) Glycerin used for this invention has the effect | action which improves the taste of the polyvalent metal salt of a component (A). The content of glycerin is 2 to 9% by mass in the liquid oral composition from the viewpoint of maintaining the bitterness, astringency improving effect and astringent feeling during and after application of the composition of the present invention in the oral cavity, and more preferably. Is 2.5 to 8.5 mass%, more preferably 3 to 8 mass%. When the content of glycerin is small, the effect of improving the taste is not sufficient, and when it is too much, the sweetness is too strong, the aftertaste is deteriorated and the astringent feeling is lost.
本発明に用いられる(C)スクラロースは人工甘味料であり、液体口腔用組成物中に0.002〜0.01質量%含有する。この含有量の範囲としたときに、(B)グリセリン及び(D)糖アルコールとの相互作用により、口腔内への適用時だけでなく、適用後までも苦味や渋味が低減され、使用感が良好になる。好ましい含有量は0.0025〜0.009質量%であり、特に好ましくは0.003〜0.008質量%である。 (C) Sucralose used in the present invention is an artificial sweetener and is contained in the liquid oral composition in an amount of 0.002 to 0.01% by mass. When the content is within this range, the interaction with (B) glycerin and (D) sugar alcohol reduces bitterness and astringency not only during application to the oral cavity but also after application. Will be better. The preferred content is 0.0025 to 0.009 mass%, particularly preferably 0.003 to 0.008 mass%.
本発明に用いられる(D)糖アルコールとしては、エリスリトール、キシリトール、マルチトール、マンニトール、ソルビトール、ラクチトール、α−D−グルコピラノシル−1,6ーマンニトール、α−D−グルコピラノシル−1,6ーソルビトール等が挙げられ、このうちエリスリトール、キシリトール、マルチトールが好ましい。これらは1種又は2種以上を組み合わせて用いることができる。(D)糖アルコールの含有量は、液体口腔用組成物中に0.5〜10質量%であり、1〜10質量%が好ましく、特に3〜7質量%が好ましい。この含有量の範囲であれば、多価金属塩の収斂作用を保持し、かつ口腔内適用中及び適用後の苦味、渋味改善効果が良好である。 Examples of the (D) sugar alcohol used in the present invention include erythritol, xylitol, maltitol, mannitol, sorbitol, lactitol, α-D-glucopyranosyl-1,6-mannitol, α-D-glucopyranosyl-1,6-sorbitol and the like. Of these, erythritol, xylitol, and maltitol are preferable. These can be used alone or in combination of two or more. (D) Content of sugar alcohol is 0.5-10 mass% in a liquid oral cavity composition, 1-10 mass% is preferable, and 3-7 mass% is especially preferable. Within this content range, the astringent action of the polyvalent metal salt is maintained, and the bitterness and astringency improving effect during and after application in the oral cavity is good.
成分(B)と成分(A)との質量比(B/A)は、収斂感を損なわずに苦味及び渋味改善効果の点から、20〜90であって、好ましくは25〜85であって、特に30〜80が好ましい。 The mass ratio (B / A) of the component (B) to the component (A) is 20 to 90, preferably 25 to 85, from the viewpoint of improving the bitterness and astringency without impairing the astringency. In particular, 30 to 80 is preferable.
成分(C)と成分(A)との質量比(C/A)は、適用時及び後味における収斂感の維持と苦味及び渋味改善の両立から、0.02〜0.1であって、好ましくは0.025〜0.9であって、特に0.03〜0.08が好ましい。 The mass ratio (C / A) between the component (C) and the component (A) is 0.02 to 0.1 from the standpoint of maintaining astringency and improving bitterness and astringency during application and aftertaste, Preferably it is 0.025-0.9, and 0.03-0.08 is especially preferable.
また、成分(A)と成分(B)及び甘味度を考慮し調整した(C)の合計量との質量比(A/(B+C×875))は、収斂作用、組成物適用中及び適用後の味の点から0.007〜0.0135が好ましく、さらに0.0077〜0.0132が好ましい。 In addition, the mass ratio (A / (B + C × 875)) of the component (A), the component (B), and the total amount of (C) adjusted in consideration of the sweetness degree is astringent, during application of the composition and after application From the point of the taste, 0.007 to 0.0135 is preferable, and 0.0077 to 0.0132 is more preferable.
また、成分(B)と成分(D)の合計含有量は、収斂作用の維持と、組成物適用中及び適用後の味の点から、5〜15質量%が好ましく、さらに6〜12質量%が好ましい。 In addition, the total content of the component (B) and the component (D) is preferably 5 to 15% by mass, more preferably 6 to 12% by mass from the viewpoint of maintaining the astringent action and taste during and after application of the composition. Is preferred.
本発明の液体口腔用組成物中の(E)水の含有量は、使用感の点で75〜95質量%が好ましく、さらに77〜93質量%が好ましく、特に80〜93質量%が好ましい。 The content of (E) water in the liquid oral cavity composition of the present invention is preferably 75 to 95% by mass, more preferably 77 to 93% by mass, and particularly preferably 80 to 93% by mass in terms of the feeling of use.
本発明の液体口腔用組成物には(F)エタノールを含有させてもよいが、エタノールは苦味、刺激の点から含有しないか又は液体口腔用組成物中に10質量%以下とするのが好ましく、さらに8質量%以下とすることが好ましく、特に6質量%以下とすることが好ましい。 The liquid oral composition of the present invention may contain (F) ethanol, but ethanol is preferably not contained from the viewpoint of bitterness and irritation, or preferably 10% by mass or less in the liquid oral composition. Further, it is preferably 8% by mass or less, and particularly preferably 6% by mass or less.
本発明の液体口腔用組成物には、前記成分の他、例えば、界面活性剤、グリセリン以外の湿潤剤、pH調整剤、保存料、殺菌剤、酵素、金属塩以外の薬効成分、顔料、色素、香料等を適宜含有させることができる。 In the liquid oral cavity composition of the present invention, in addition to the above components, for example, surfactants, wetting agents other than glycerin, pH adjusters, preservatives, bactericides, enzymes, medicinal components other than metal salts, pigments, dyes A fragrance or the like can be appropriately contained.
界面活性剤としては、陰イオン界面活性剤、非イオン界面活性剤、陽イオン界面活性剤、及び両性界面活性剤等が挙げられる。このうち使用感の点から非イオン界面活性剤が好ましく、さらにポリオキシエチレン硬化ヒマシ油が好ましい。非イオン界面活性剤の含有量は、味と油成分の溶解性の点から0.3〜3質量%が好ましく、さらに0.5〜1.5質量%が好ましい。 Examples of the surfactant include an anionic surfactant, a nonionic surfactant, a cationic surfactant, and an amphoteric surfactant. Of these, nonionic surfactants are preferable from the viewpoint of feeling of use, and polyoxyethylene hydrogenated castor oil is more preferable. The content of the nonionic surfactant is preferably 0.3 to 3% by mass, more preferably 0.5 to 1.5% by mass from the viewpoint of taste and solubility of the oil component.
グリセリン以外の湿潤剤としては、ポリエチレングリコール、プロピレングリコール、エチレングリコール、1,3−ブチレングリコール、ポリプロピレングリコールなどが挙げられ、その1種又は2種以上を組み合わせて配合することができる。 Examples of the wetting agent other than glycerin include polyethylene glycol, propylene glycol, ethylene glycol, 1,3-butylene glycol, polypropylene glycol, and the like, and one or more of them can be combined.
香料としては、l−メントール、カルボン、アネトール、オイゲノール、リモネン、ペパーミント油、スペアミント油、オシメン、n−アミルアルコール、シトロネロール、α−テルピネオール、サリチル酸メチル、メチルアセテート、シトロネオールアセテート、シネオール、リナロール、エチルリナロール、ワニリン、チモール、レモン油、オレンジ油、セージ油、ローズマリー油、桂皮油、ピメント油、シソ油、丁子油、ユーカリ油、ハツカ油、アニス油、冬緑油等が挙げられる。 As a fragrance, 1-menthol, carvone, anethole, eugenol, limonene, peppermint oil, spearmint oil, ocimen, n-amyl alcohol, citronellol, α-terpineol, methyl salicylate, methyl acetate, citronole acetate, cineol, linalool, Examples include ethyl linalool, crocodile, thymol, lemon oil, orange oil, sage oil, rosemary oil, cinnamon oil, pimento oil, perilla oil, clove oil, eucalyptus oil, hatsuka oil, anise oil, and winter green oil.
pH調整剤としては、例えば、乳酸、乳酸ナトリウム等の一塩基酸及びその塩、水酸化ナトリウム、水酸化カリウム等が挙げられ、これらを組み合わせて配合することができる。 Examples of the pH adjuster include monobasic acids such as lactic acid and sodium lactate and salts thereof, sodium hydroxide, potassium hydroxide, and the like, and these can be used in combination.
本発明の液体口腔用組成物は、洗口剤、液体ハミガキ、洗口液として特に有用である。 The liquid oral cavity composition of the present invention is particularly useful as a mouthwash, liquid toothpaste, and mouthwash.
次に実施例を挙げて本発明を説明する。 Next, an Example is given and this invention is demonstrated.
実施例1〜7及び比較例1〜10
表1及び表2に示す組成の洗口液を調製し、10名のパネラーにより、組成物(洗口液)10mLを口に含み、20秒間含漱した後、吐き出すことにより味及び収斂感を評価した。なお、表中に特に示さない限り、各成分の含有量は有効量(100%換算値)を示す。
Examples 1-7 and Comparative Examples 1-10
Mouthwashes with the compositions shown in Tables 1 and 2 were prepared, and 10 panelists contained 10 mL of the composition (mouthwash) in the mouth, and after squeezing for 20 seconds, the taste and astringency were felt by spitting out. evaluated. In addition, unless otherwise indicated in a table | surface, content of each component shows an effective amount (100% conversion value).
(1)収斂感
収斂感は下記の3段階の基準で評価を行い、その平均値で示した。
評価基準
1:引き締まる
2:やや引き締まる
3:変わらない
(1) Converging feeling Converging feeling was evaluated according to the following three-stage criteria, and indicated as an average value.
Evaluation criteria 1: Tighten 2: Tighten slightly 3: No change
(2)渋味(洗口中)(洗口後)
洗口中の渋味は、組成物を口に含んでいる時の渋味を評価した。洗口後の渋味は、組成物を口から吐き出した後の渋味を評価した。渋味の程度は下記の3段階の基準で味の評価を行い、その平均値で示した。
評価基準
1:渋くない
2:あまり渋くない
3:渋い
(2) Astringency (in mouthwash) (after mouthwash)
The astringency during mouthwash evaluated the astringency when the composition was included in the mouth. The astringency after mouthwash evaluated the astringency after discharging the composition from the mouth. The degree of astringency was evaluated by the taste according to the following three levels, and the average value was shown.
Evaluation criteria 1: Not astringent 2: Not very astringent 3: Astringent
(3)苦味(洗口中)(洗口後)
洗口中の苦味は、組成物を口に含んでいる時の苦味を評価した。洗口後の苦味は、組成物を口から吐き出した後の苦味を評価した。苦味の程度は下記の3段階の基準で味の評価を行い、その平均値で示した。
評価基準
1:苦くない
2:あまり苦くない
3:苦い
(3) Bitterness (in mouthwash) (after mouthwash)
The bitterness during the mouthwash was evaluated when the composition was contained in the mouth. The bitterness after mouth-washing evaluated the bitterness after discharging the composition from the mouth. The degree of bitterness was evaluated based on the following three levels, and the average value was shown.
Evaluation criteria 1: Not bitter 2: Not bitter 3: Bitter
結果を表1及び表2に示す。 The results are shown in Tables 1 and 2.
表1及び表2より、(E)水を多量に含有し、(A)多価金属塩、(B)グリセリン、(C)スクラロース及び(D)糖アルコールを一定量の範囲に調整した本発明の液体口腔用組成物(洗口液)は、優れた収斂感を維持しつつ、口腔に適用中及び適用後の苦味及び渋味が抑制され使用感が良好であることがわかる。 From Tables 1 and 2, the present invention comprises (E) a large amount of water and (A) a polyvalent metal salt, (B) glycerin, (C) sucralose, and (D) a sugar alcohol adjusted to a certain range. It can be seen that the liquid oral composition (mouth rinse) maintains a good astringent feeling while suppressing the bitterness and astringency during application to the oral cavity and after application, and good usability.
Claims (3)
(A)アラントインクロルヒドロキシアルミニウム、及びアラントインジヒドロキシアルミニウムから選ばれる水溶性アルミニウム塩 0.02〜0.3質量%、
(B)グリセリン 2〜9質量%、
(C)スクラロース 0.002〜0.01質量%、
(D)エリスリトール、キシリトール、及びマルチトールから選ばれる糖アルコール 0.5〜10質量%、及び
(E)水 75〜93質量%
を含有し、成分(B)と成分(A)の質量比(B/A)が30〜80であって、
成分(C)と成分(A)の質量比(C/A)が0.02〜0.1であり、かつ成分(B)と成分(D)の合計含有量が5〜12質量%である液体口腔用組成物。 The following components (A) to (E):
(A) 0.02 to 0.3% by mass of a water-soluble aluminum salt selected from allantoinchlorohydroxyaluminum and allantoindihydroxyaluminum ,
(B) Glycerin 2-9% by mass,
(C) Sucralose 0.002-0.01% by mass,
(D) erythritol, xylitol, and sugar alcohols 0.5 to 10 wt% selected from maltitol, and (E) water 75 to 93 wt%
The mass ratio (B / A) of the component (B) and the component (A) is 30 to 80 ,
Weight ratio of component (C) with component (A) (C / A) is Ri der 0.02 to 0.1, and a total content of 5-12 wt% of component (B) and the component (D) Oh Ru liquid oral compositions.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010291908A JP5710241B2 (en) | 2010-12-28 | 2010-12-28 | Liquid oral composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010291908A JP5710241B2 (en) | 2010-12-28 | 2010-12-28 | Liquid oral composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012140333A JP2012140333A (en) | 2012-07-26 |
JP5710241B2 true JP5710241B2 (en) | 2015-04-30 |
Family
ID=46677022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010291908A Active JP5710241B2 (en) | 2010-12-28 | 2010-12-28 | Liquid oral composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5710241B2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6505358B2 (en) * | 2013-09-30 | 2019-04-24 | 小林製薬株式会社 | Astringent composition |
JP6441669B2 (en) * | 2014-12-26 | 2018-12-19 | 花王株式会社 | Liquid oral composition |
JP2017141178A (en) * | 2016-02-09 | 2017-08-17 | ライオン株式会社 | Dentifrice composition |
JP6628839B2 (en) * | 2018-06-28 | 2020-01-15 | 小林製薬株式会社 | Astringent composition |
ES2837877A1 (en) * | 2019-12-31 | 2021-07-01 | Laboratorios Vinas S A | GALENIC COMPOSITION, FOR ORAL USE, LIQUID, INCLUDING MELATONIN AND A ZINC SALT AND CORRESPONDING METHOD AND USE (Machine-translation by Google Translate, not legally binding) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3877412B2 (en) * | 1996-12-16 | 2007-02-07 | アース製薬株式会社 | Liquid oral composition |
JP2007008824A (en) * | 2005-06-28 | 2007-01-18 | Lion Corp | Composition for oral cavity |
JP4849980B2 (en) * | 2006-07-12 | 2012-01-11 | 花王株式会社 | Toothpaste composition |
JP2008031070A (en) * | 2006-07-27 | 2008-02-14 | Kao Corp | Liquid composition for oral cavity |
US8372821B2 (en) * | 2008-04-09 | 2013-02-12 | Jack H. Owoc | Stable aqueous compositions comprising bioactive creatine species |
JP5613990B2 (en) * | 2009-03-25 | 2014-10-29 | ライオン株式会社 | Tooth dentinal tubule sealant and oral composition |
JP2010132708A (en) * | 2010-03-05 | 2010-06-17 | Taisho Pharmaceutical Co Ltd | Liquid pharmaceutical composition containing iron compound for oral administration |
-
2010
- 2010-12-28 JP JP2010291908A patent/JP5710241B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2012140333A (en) | 2012-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5613990B2 (en) | Tooth dentinal tubule sealant and oral composition | |
JP4482270B2 (en) | Oral composition | |
JP5710241B2 (en) | Liquid oral composition | |
CN106999363B (en) | Oral composition | |
JP2002029950A (en) | Zinc compound-containing composition for oral cavity | |
JP5398102B2 (en) | Oral or throat bactericidal composition | |
JP4645830B2 (en) | Dentifrice composition and method for improving dry resistance of dentifrice composition | |
JP6441669B2 (en) | Liquid oral composition | |
WO2018066341A1 (en) | Oral composition and method for suppressing discoloration of formulation and liquid separation thereof | |
JP5570777B2 (en) | Oral composition | |
JP4044748B2 (en) | Oral liquid composition | |
JP4539832B2 (en) | Dentifrice composition | |
JP3987593B2 (en) | Oral composition containing sodium chloride and magnesium chloride | |
JP2000178150A (en) | Liquid composition for oral cavity | |
JP6528762B2 (en) | Toothpaste composition | |
JP3582571B2 (en) | Oral liquid preparation | |
CN111902125B (en) | Oral composition and bitterness improver of alpha-olefin sulfonate | |
JP2000026257A (en) | Oral composition | |
JP2001064136A (en) | Composition for oral cavity | |
JP3511727B2 (en) | Oral composition | |
JPWO2019216108A1 (en) | Oral composition | |
JP4102458B2 (en) | Oral composition | |
JP6249588B2 (en) | Oral composition | |
JP2000281550A (en) | Composition for oral cavity | |
KR102044938B1 (en) | Toothpaste composition for using pumping type container |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130918 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140522 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140603 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140804 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150224 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150304 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 5710241 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |